Thyroid Dysfunction and Autoimmunity as Emerging Biomarkers in the Progression of Diabetic Nephropathy in Type 2 Diabetes Mellitus

Authors

  • Nagwa Samy Ibrahim Said, Shaimaa Elsayed Ahmed Ibrahim Hadhod , Alhoussein Alsayed Abdelaal Author

DOI:

https://doi.org/10.48047/7t8a6h88

Keywords:

Thyroid Dysfunction, Diabetic Nephropathy, Type 2 Diabetes Mellitus

Abstract

Background: Diabetic nephropathy (DN) remains one of the most significant microvascular complications of type 2 diabetes mellitus (T2DM) and is a leading cause of end-stage renal disease worldwide. Despite advances in glycemic control and renoprotective therapies, the early detection of DN continues to pose clinical challenges. Traditional biomarkers such as albuminuria and estimated glomerular 

Downloads

Download data is not yet available.

References

International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: IDF; 2021.

Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032-2045.

Downloads

Published

2024-11-20

How to Cite

Thyroid Dysfunction and Autoimmunity as Emerging Biomarkers in the Progression of Diabetic Nephropathy in Type 2 Diabetes Mellitus (Nagwa Samy Ibrahim Said, Shaimaa Elsayed Ahmed Ibrahim Hadhod , Alhoussein Alsayed Abdelaal , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6241-6252. https://doi.org/10.48047/7t8a6h88